Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 171 - 180 of 244 for simcere. (0.12 seconds)

PerkinElmer paid $38 million to buy Shanghai Haoyuan...
In an exclusive ChinaBio® Today interview, Dr. Jun...
Mindray Medical will pay $105 million to acquire Zonare...
Apexigen, a California antibody company with strong...
Kanghong Pharma Group was granted CFDA approval for a...
WuXi PharmaTech, through its WuXi NextCODE Genomics...
CBT 200 Off By 2 Points. More details...
Acquisitions in the Future -- As expected, a group...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here